Progestin-only contraception is first line for sickle cell disease: a comment on "Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias.".
Publication/Presentation Date
8-1-2023
Volume
7
Issue
6
First Page
102183
Last Page
102183
ISSN
2475-0379
Published In/Presented At
Pecker, L. H., Burke, A., Streiff, M. B., Lanzkron, S., & Naik, R. P. (2023). Progestin-only contraception is first line for sickle cell disease: a comment on "Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias.". Research and practice in thrombosis and haemostasis, 7(6), 102183. https://doi.org/10.1016/j.rpth.2023.102183
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
37711908
Department(s)
Administration and Leadership
Document Type
Article
COinS